What is Inogen?
Headquartered in Goleta, California, and established in 2001, Inogen has carved out a significant niche in the medical technology industry. The firm specializes in the development and manufacturing of portable oxygen concentrators, which are essential for patients suffering from chronic respiratory conditions. By prioritizing mobility and patient autonomy, Inogen has transformed the standard of care for long-term oxygen therapy. Its market position is defined by a robust portfolio of respiratory devices that cater to both clinical environments and individual home-care needs, reflecting a deep integration of engineering precision and patient-centric design.
How much funding has Inogen raised?
Inogen has raised a total of $27.2M across 1 funding round:
Other Financing Round
$27.2M
Other Financing Round (2025): $27.2M with participation from Yuwell Global
Key Investors in Inogen
Yuwell Global
Yuwell Global specializes in the development and manufacturing of medical devices and healthcare products, with a strong emphasis on respiratory equipment and rehabilitation solutions.
What's next for Inogen?
With the recent strategic investment, Inogen is well-positioned to accelerate its research and development initiatives, focusing on the next generation of respiratory health technology. The company is expected to utilize these funds to optimize its supply chain and expand its global distribution network, addressing the growing demand for portable medical equipment. As Inogen moves forward, the focus will likely remain on maintaining its competitive edge through technological innovation and strategic partnerships, ensuring that its product offerings continue to meet the evolving regulatory and clinical standards of the global healthcare market.
See full Inogen company page
